Other Applications

AmpliPhi Biosciences’s proprietary phage technology and extensive library of phage products provides potential applications for a broad array of treatment needs. Initial studies have indicated that bacteriophages can work synergistically with traditional antibiotics, enabling products to be effective against otherwise resistant strains. In addition, phage treatments may prove effective for a variety of topical infections, including burns and wounds.

Latest News

March 27th 2012

“Using Viruses to Beat Superbugs,” AmpliPhi CSO Dr. David Harper featured in ScienceDaily

More

March 08th 2012

“The Bacteriophage Comes of Age” in Medscape News

More

January 31st 2012

January 2012 Shareholder Letter

More

January 04th 2012

BioWorld Today features AmpliPhi CEO Phil Young

More

November 21st 2011

AmpliPhi Biosciences Announces First Closing of $2.7m

More